NCT07267026
- Conditions
- FSGS, MCD, Macular dystrophy, corneal type 1
- Locations
-
- Q-Pharm Pty Ltd. Herston, Queensland, Australia
Clinical trial condition
Explore clinical trials studying Macular dystrophy, corneal type 1. Study availability and eligibility vary by location and protocol.
NCT07267026
NCT06983028
NCT04571658
NCT01209000
NCT05003986
NCT05650619
NCT02817997
NCT03949972
NCT00092222
NCT03933904